Risk‐reducing simple mastectomy, subcutaneous mastectomy and skin‐sparing mastectomy have all been demonstrated to be associated with breast cancer risk reduction in patients with a strong family history of breast cancer and in patients with mutations in BRCA1 and BRCA2 genes1, 2, 3. The gene discussed is BRCA2; the disease is breast carcinoma.